Added to YB: 2025-05-06
Pitch date: 2025-05-04
LOVE.V [neutral]
Cannara Biotech Inc.
+28.57%
current return
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
Market Cap
CAD 164.2M
Pitch Price
CAD 1.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
6.75
P/E
12.36
EV/Sales
1.79
Sector
Personal Care Products
Category
growth
Cannara Biotech ($LOVE.V) FINS Review
LOVE.V (earnings update): Quebec producer w/ 35% Q2 rev growth to $26.6M. GP margins +1000bp to 42.8%. Net income $5.6M vs -$1.34M last yr. Priced at $130M cap w/ $48.3M debt. 2.3x current ratio but mainly inventory. Strong Quebec share, insiders own 50%. Concerns: 55% marketing cost growth, cash flow volatility, insider board/debt arrangements.
Read full article (5 min)